Trial Profile
Phase Ib clinical study evaluated the safety, tolerability, and pharmacokinetic characteristics of human recombinant interleukin-1 receptor antagonist in cancer patients received FOLFIRI chemotherapy
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Mar 2018
Price :
$35
*
At a glance
- Drugs GR 007 (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 23 Mar 2018 New trial record